Laurent Weekers
About
In The Last Decade
Laurent Weekers
72 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 95
- Nephrology 448
- Surgery 428
- Immunology 351
- Transplantation 344
- Public Health, Environmental and Occupational Health 232
Countries citing papers authored by Laurent Weekers
This map shows the geographic impact of Laurent Weekers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Weekers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Weekers more than expected).
Fields of papers citing papers by Laurent Weekers
This network shows the impact of papers produced by Laurent Weekers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Weekers. The network helps show where Laurent Weekers may publish in the future.
Co-authorship network of co-authors of Laurent Weekers
This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Weekers. A scholar is included among the top collaborators of Laurent Weekers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Weekers. Laurent Weekers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 12 | |
| 5 | 14 | |
| 6 | "Acute kidney dysfunction with no rejection (ADNR)" is associated with poor outcomes in kidney transplant recipients | 1 |
| 7 | 219 | |
| 8 | Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis | 1 |
| 9 | 9 | |
| 10 | 61 | |
| 11 | Infusion of third party mesenchymal stem cells (MSC) after kidney and liver transplantation: a phase I-II, open-label, clinical study | 2 |
| 12 | 22 | |
| 13 | 19 | |
| 14 | 14 | |
| 15 | Les anticorps monoclonaux en transplantation rénale | 0 |
| 16 | 11 | |
| 17 | La néphropathie diabétique | 2 |
| 18 | Lack of contribution of two endotelial nitric oxide synthase (eNOS) gene polymorphisms to diabetic nephropathy in type 1 diabetes | 4 |
| 19 | Contribution of Angiotensin I Converting Enzyme I/D polymorphism to the development and progression of diabetic nephropathy in type 1 diabetes: a 6-year follow-up observational study | 1 |
| 20 | Organic silicon decreases interleukine-6 but not leukemia inhibitory factor in human osteoblast-like cells in vitro | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.